Endogenous Progenitors Cell Therapy for Diabetic Foot Ulcers

NCT01353937 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Never Activated

Conditions

Diabetic Ulcer

Interventions

DRUG: AMD3100 injection + rhPDGF-BB topical

Sponsor

NYU Langone Health

Collaborators

[object Object]
[object Object]